Related Articles
Tranilast strongly sensitizes pancreatic cancer cells to gemcitabine via decreasing protein expression of ribonucleotide reductase 1
Ribonucleotide reductase subunit M1 assessed by quantitative double-fluorescence immunohistochemistry predicts the efficacy of gemcitabine in biliary tract carcinoma
Advanced squamous lung carcinoma in a patient experiencing long-term survival following repeated responses to gemcitabine and cisplatin chemotherapy: A case report
Preclinical rationale for synergistic interaction of pemetrexed and cytotoxic nucleoside analogues
Establishment of human pancreatic cancer gemcitabine‑resistant cell line with ribonucleotide reductase overexpression